The effectiveness of immunomodulatory therapy with a synthetic analogue of the active center of the hormone thymus thymopoietin in the complex treatment of immunocompromised women with chronic infectious and inflammatory diseases of the pelvic organs
Open Access
- 11 August 2023
- journal article
- research article
- Published by Russian Society of Immunology in Russian Journal of Immunology
- Vol. 26 (3) , 287-294
Abstract
Chronic inflammatory diseases of the pelvic organs (pelvic inflammatory disease, PID) in women is among the main understudied problems in gynecology worldwide with adverse medical and socio-economic consequences, thus justifying the need for further study of immunopathogenesis and development of new approaches to treatment. Our objective was to develop new immunotherapeutic approaches to correction of combined disorders of the immune system functioning in immunocompromised women with PID and to evaluate their clinical and immunological efficacy. 55 women aged 20-40 years were examined, i.e., 35 patients with exacerbation of sluggish or recurrent PID, resistant to conventional therapy. Testiung was performed before complex treatment (study group 1 GI- 1) and after the course (study group 2 GI-2). Contents of T and B lymphocytes, natural killer cells (NK) (CYTOMICS FC500, USA), phagocytic and microbicidal functions of neutrophilic granulocytes (NG) were assessed in SG-1 and SG-2 before and 2-3 days after complex treatment with addition of an immunotherapeutic drug based on hexapeptide (HP) at a daily dose of 45 mg/ml intramuscularly for 10 days. In patients from SG-1, a decrease in T cells (CD3+CD19- ) and B cells (CD3-CD19+), a 2-fold increase in the content of NK CD3-CD16+CD56+ was found, along with altered functioning of NG (deficiency of actively phagocytizing NG, a decrease in their digestive function and NADPH-oxidase activity). In SG-2 patients, the treatment was followed by restoration of the T (CD3+CD19-) and B cells (CD3-CD19+), NK cells (CD3-CD16+CD56+), like as an increase in effector functions, i.e., microbial capture by NG and their killing ability due to activation of NADPH oxidases and normalization of microbicidal reserve capacity in the NG cell population. Positive clinical effect included reduction of clinical symptoms in acute period, absence of PID exacerbations over follow-up for 6 months (85.6% of cases). Occasional exacerbations of PID were associated with medical manipulations (5.7%) and unprotected sexual contacts (5.7%). The immunopathogenetically proven approach to correction of combined functional impairment of immune system in the women with PID shows a positive clinical and immunological effect.Keywords
This publication has 11 references indexed in Scilit:
- Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory diseaseAmerican Journal of Obstetrics and Gynecology, 2021
- Optimization of complex therapy of inflammatory diseases of women pelvic organsGYNECOLOGY, 2019
- Antibiotic resistance – a modern global health problem. The search for possible solutions in treating PIDMeditsinskiy sovet = Medical Council, 2018
- Immunotherapy as a way to increase the effectiveness of comprehensive treatment of pelvic inflammatory diseasesRussian Journal of Woman and Child Health, 2018
- Polymicrobial associations in the etiology of inflammatory diseases of the female genital organsAkusherstvo i ginekologiia, 2017
- Characteristics of the vaginal microbiota with a combination of bacterial vaginosis with the pathology of the vagina and cervix inflammatory genesisGYNECOLOGY, 2017
- FEATURES OF THE IMMUNE STATUS OF WOMEN OF REPRODUCTIVE AGE SUFFERING FROM GENITAL INFECTIOUS-INFLAMMATORY PROCESSESKuban Scientific Medical Bulletin, 2017
- Immunotherapy in combination treatment of bacterial genitourinary tract infectionsConsilium Medicum, 2017
- Identification of novel microbes associated with pelvic inflammatory disease and infertilitySexually Transmitted Infections, 2016
- Place of immunomodulators in the treatment of pelvic inflammatory diseasesGYNECOLOGY, 2016